Back to Search
Start Over
Real-life data of major and minor bleeding events with direct oral anticoagulants in the one-year follow-up period: The NOAC-TURK study
- Source :
- Anatol J Cardiol, Anatolian Journal of Cardiology, Vol 25, Iss 3, Pp 196-204 (2021)
- Publication Year :
- 2021
- Publisher :
- Turkish Society of Cardiology, 2021.
-
Abstract
- OBJECTIVE: This study aimed to evaluate the safety of direct oral anticoagulants (DOACs) in patients with non-valvular atrial fibrillation (NVAF) during daily clinical practice. METHODS: This was a prospective study conducted between January 01, 2016, and April 01, 2017, in patients aged ≥18 years with a diagnosis of NVAF. We performed the study in 9 clinical centers from different regions of Turkey, and the mean follow-up period was 12+2 months. We investigated major and minor bleeding events of DOAC. RESULTS: A total of 1807 patients with NVAF were enrolled. The mean age of the patients was 73.6±10.2 years, CHA2DS2-VASc score was 3.6±1.4, and HAS-BLED score was 2±1.2. The most frequently prescribed DOAC was dabigatran 110 mg bid in 409 (22.6%) patients. The patients on apixaban 2.5 mg bid were older (p
- Subjects :
- Adult
medicine.medical_specialty
One year follow up
Adolescent
Pyridones
Administration, Oral
Hemorrhage
Dabigatran
Rivaroxaban
Internal medicine
Atrial Fibrillation
medicine
Diseases of the circulatory (Cardiovascular) system
Humans
In patient
cardiovascular diseases
Prospective Studies
Prospective cohort study
Original Investigation
Aged
Aged, 80 and over
business.industry
Anticoagulants
Atrial fibrillation
Middle Aged
medicine.disease
Real life data
Stroke
RC666-701
cardiovascular system
Apixaban
Cardiology and Cardiovascular Medicine
business
medicine.drug
Follow-Up Studies
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Anatol J Cardiol, Anatolian Journal of Cardiology, Vol 25, Iss 3, Pp 196-204 (2021)
- Accession number :
- edsair.doi.dedup.....0cf8f7d9ff0518d961c04ee29db27de4